Severe and fatal COVID-19 is characterised by increased circulating glucagon like peptide 1 and procalcitonin modulated by type 2 diabetes

Olga Bloch*, Perl Kobi, Ariel Ben Shimol, Assaf Rotmensh, Dana Kagansky, Dana Zelnik-Yovel, Gilad Ben Yehudah, Dror Cantrell, Micha J. Rapoport

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Severe and fatal COVID-19 is characterised by increased circulating glucagon like peptide 1 and procalcitonin modulated by type 2 diabetes'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology